http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104068391-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23P10-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L19-00 |
| filingDate | 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104068391-B |
| titleOfInvention | The aloe Momordica grosvenori compound capsule that a kind of mogroside IV content is high |
| abstract | The invention discloses the aloe Momordica grosvenori compound capsule that a kind of mogroside IV content is high, this capsule has the effect of prophylactic treatment the third liver. Adopt following proportioning, in butt % by weight: primary colors aloe leaf freeze dried powder 5-10; The Fructus Monordicae extract 8-12 that mogroside IV content is 15%-55%; Honegsukle flower P.E 6-12; Isatis root extract 4-8; Cornstarch 30-40; Maltodextrin 10-25; Microcrystalline cellulose 10-15; In finished product, functional component content is: in every 100g product, mogroside IV content is 1200-6600mg, and O-acetyl content is greater than 800mg. Positive usual amounts is every day 2-3 time, 1-2 grain at every turn. |
| priorityDate | 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.